STARt-001 is the first clinical study to evaluate Marengo's novel, selective Vβ TCR agonist technology to promote in vivo expansion and reprogramming of tumor-infiltrating lymphocytes (TILs) in...

-ST101 Phase 2 data demonstrates activation of the tumor immune microenvironment in glioblastoma (GBM)- -ST316 Phase 1 data demonstrates antagonism of β-catenin-driven immune exclusion-...

The International Luxury Hotel Association (ILHA) is thrilled to announce that its highly anticipated INSPIRE Luxury Hospitality Conference, scheduled for December 4-5, 2024, at the prestigious...

Jack Henry & Associates, Inc.® (Nasdaq: JKHY) is pleased to announce that President & CEO Greg Adelson and Chief Financial Officer & Treasurer Mimi Carsley will present at several conferences in...

Aviat Networks, Inc. (NASDAQ: AVNW), the leading expert in wireless transport and access solutions, today announced that it will participate in the following upcoming investor conferences. 18th...